A Study of VAH631 in Patients With Essential Hypertension (Factorial Study)

NCT00311740 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

582

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: Valsartan
DRUG: Hydrochlorothiazide

Sponsor

Novartis